Meiotic cellular rejuvenation is coupled to nuclear remodeling in budding yeast

Abstract

Production of healthy gametes in meiosis relies on the quality control and proper distribution of both nuclear and cytoplasmic contents. Meiotic differentiation naturally eliminates age-induced cellular damage by an unknown mechanism. Using time-lapse fluorescence microscopy in budding yeast, we found that nuclear senescence factors - including protein aggregates, extrachromosomal ribosomal DNA circles, and abnormal nucleolar material - are sequestered away from chromosomes during meiosis II and subsequently eliminated. A similar sequestration and elimination process occurs for the core subunits of the nuclear pore complex in both young and aged cells. Nuclear envelope remodeling drives the formation of a membranous compartment containing the sequestered material. Importantly, de novo generation of plasma membrane is required for the sequestration event, preventing the inheritance of long-lived nucleoporins and senescence factors into the newly formed gametes. Our study uncovers a new mechanism of nuclear quality control and provides insight into its function in meiotic cellular rejuvenation.

Data availability

Data generated or analyzed during this study are included in the manuscript and supporting files. All imaging data used for analysis will be uploaded to the Image Data Resource repository.

Article and author information

Author details

  1. Grant A King

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  2. Jay S Goodman

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  3. Jennifer G Schick

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  4. Keerthana Chetlapalli

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  5. Danielle M Jorgens

    Electron Microscope Lab, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  6. Kent L McDonald

    Electron Microscope Lab, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  7. Elçin Ünal

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    For correspondence
    elcin@berkeley.edu
    Competing interests
    Elçin Ünal, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6768-609X

Funding

National Institutes of Health (DP2 AG055946-01)

  • Elçin Ünal

Pew Charitable Trusts (00027344)

  • Elçin Ünal

Damon Runyon Cancer Research Foundation (35-15)

  • Elçin Ünal

Glenn Foundation for Medical Research

  • Elçin Ünal

National Science Foundation (DGE 1752814)

  • Grant A King

National Institutes of Health (T32 GM007232)

  • Grant A King

National Institutes of Health (F31AG060656)

  • Jay S Goodman

National Institutes of Health (T32 GM007127-41)

  • Jay S Goodman

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2019, King et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 7,976
    views
  • 62
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Grant A King
  2. Jay S Goodman
  3. Jennifer G Schick
  4. Keerthana Chetlapalli
  5. Danielle M Jorgens
  6. Kent L McDonald
  7. Elçin Ünal
(2019)
Meiotic cellular rejuvenation is coupled to nuclear remodeling in budding yeast
eLife 8:e47156.
https://doi.org/10.7554/eLife.47156

Share this article

https://doi.org/10.7554/eLife.47156

Further reading

    1. Cell Biology
    Kaili Du, Hongyu Chen ... Dan Li
    Research Article

    Niemann–Pick disease type C (NPC) is a devastating lysosomal storage disease characterized by abnormal cholesterol accumulation in lysosomes. Currently, there is no treatment for NPC. Transcription factor EB (TFEB), a member of the microphthalmia transcription factors (MiTF), has emerged as a master regulator of lysosomal function and promoted the clearance of substrates stored in cells. However, it is not known whether TFEB plays a role in cholesterol clearance in NPC disease. Here, we show that transgenic overexpression of TFEB, but not TFE3 (another member of MiTF family) facilitates cholesterol clearance in various NPC1 cell models. Pharmacological activation of TFEB by sulforaphane (SFN), a previously identified natural small-molecule TFEB agonist by us, can dramatically ameliorate cholesterol accumulation in human and mouse NPC1 cell models. In NPC1 cells, SFN induces TFEB nuclear translocation via a ROS-Ca2+-calcineurin-dependent but MTOR-independent pathway and upregulates the expression of TFEB-downstream genes, promoting lysosomal exocytosis and biogenesis. While genetic inhibition of TFEB abolishes the cholesterol clearance and exocytosis effect by SFN. In the NPC1 mouse model, SFN dephosphorylates/activates TFEB in the brain and exhibits potent efficacy of rescuing the loss of Purkinje cells and body weight. Hence, pharmacological upregulating lysosome machinery via targeting TFEB represents a promising approach to treat NPC and related lysosomal storage diseases, and provides the possibility of TFEB agonists, that is, SFN as potential NPC therapeutic candidates.

    1. Cell Biology
    2. Developmental Biology
    Sarah Y Coomson, Salil A Lachke
    Insight

    A study in mice reveals key interactions between proteins involved in fibroblast growth factor signaling and how they contribute to distinct stages of eye lens development.